May 19, 2014 | Keystone Heart, a medical device company and the developer of the TriGuard Cerebral Protection Device, has successfully raised $14 million in a Series B round of financing led by OrbiMed. OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, managing approximately $11 billion across public and private company investments.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments